Smartphone app-based approximation of time spent with atrial fibrillation and symptoms in patients after catheter ablation: data from the TeleCheck-AF project

Abstract Aims Reduction of atrial fibrillation (AF) burden is the preferred outcome measure over categorical AF rhythm recurrence after AF ablation. In this sub-analysis of the TeleCheck-AF project, we tested the feasibility of smartphone app-based approximation of time spent with AF and/or symptoms...

Full description

Saved in:
Bibliographic Details
Published inEuropace (London, England) Vol. 26; no. 10
Main Authors Sandgren, Emma, Hermans, Astrid N L, Gawalko, Monika, Betz, Konstanze, Sohaib, Afzal, Fung, Chi Ho, Hillmann, Henrike A K, van der Velden, Rachel M J, Verhaert, Dominique, Scherr, Daniel, Sultan, Arian, Steven, Daniel, Pisters, Ron, Hemels, Martin, Lodziński, Piotr, Chaldoupi, Sevasti-Maria, Gupta, Dhiraj, Gruwez, Henri, Pluymaekers, Nikki A H A, Hendriks, Jeroen M, Nørregaard, Malene, Manninger, Martin, Duncker, David, Linz, Dominik
Format Journal Article
LanguageEnglish
Published UK Oxford University Press 03.10.2024
Subjects
Clinical Research
Photoplethysmography
AF burden
AF symptoms
Atrial fibrillation
Catheter ablation
Mobile health
atrial fibrillation
catheter ablation
mobile health
photoplethysmography
Online AccessGet full text
ISSN1099-5129
1532-2092
1532-2092
DOI10.1093/europace/euae247

Cover

More Information
Summary:Abstract Aims Reduction of atrial fibrillation (AF) burden is the preferred outcome measure over categorical AF rhythm recurrence after AF ablation. In this sub-analysis of the TeleCheck-AF project, we tested the feasibility of smartphone app-based approximation of time spent with AF and/or symptoms. Methods and results Patients scheduled for at least one teleconsultation during the 12-month follow-up after AF ablation were instructed to use a smartphone photoplethysmography-based application for simultaneous symptom and rhythm monitoring three times daily for 1 week. Proxies of time spent with AF and/or symptoms (% recordings, load, and % days), temporal aggregation of AF and/or symptoms (density), and symptom–rhythm correlation (SRC) were assessed. In total, 484 patients (60% male, 62 ± 9.9 years) were included. Adherence, motivation, and patient satisfaction were high. %AF recordings, AF load, and %AF days (rs = 0.88–0.95) and %symptom recordings, symptom load, and %symptom days (rs = 0.95–0.98) showed positive correlations. The SRC correlated negatively with time spent with symptoms (rs = −0.65–0.90) and with time spent with AF (rs = −0.31–0.34). In patients with paroxysmal AF before ablation and AF during the monitoring period, 87% (n = 39/44) had a low-density score <50% (‘paroxysmal AF pattern’) while 5% (n = 2/44) had a high-density score >90% (‘persistent AF pattern’). Corresponding numbers for patients with persistent AF before ablation were 48% (n = 11/23) and 43% (n = 10/23), respectively. Conclusion On-demand, app-based simultaneous rhythm and symptom assessment provides objective proxies of time spent with AF and/or symptoms and SRC, which may assist in assessing AF and symptom outcomes after AF ablation. Graphical Abstract Graphical Abstract
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Emma Sandgren, Astrid N L Hermans, Monika Gawalko and Konstanze Betz contributed equally to this work.
Conflict of interest: E.S., A.N.L.H., M.G., K.B., A.So., C.H.F., R.M.J.v.d.V., D.V., D.Sc., A.Su., D.St., R.P., M.H., P.L., D.G., H.G., N.A.H.A.P., J.M.H., M.N., M.M., and D.L. declared no conflict of interests. D.D. received modest lecture honorary, travel grants, and/or a fellowship grant from Abbott, AstraZeneca, Biotronik, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, CVRx, Medtronic, Microport, Pfizer, Sanofi, and Zoll. H.A.K.H. received modest lecture honorary and/or a fellowship grant from AstraZeneca, Boston Scientific, and Zoll.
ISSN:1099-5129
1532-2092
1532-2092
DOI:10.1093/europace/euae247